scholarly article | Q13442814 |
P356 | DOI | 10.1093/ABBS/GMW124 |
P8608 | Fatcat ID | release_ewjp5s3tcnhjhff53f7p6ajly4 |
P698 | PubMed publication ID | 28069585 |
P2093 | author name string | Zhen Yang | |
Xin Cai | |||
Qingguo Li | |||
Yanxia Liu | |||
Gaofeng Pan | |||
Hongjian Ding | |||
Weiyan Liu | |||
P2860 | cites work | HMG1 and 2: architectural DNA-binding proteins | Q22121969 |
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Targeting cellular metabolism to improve cancer therapeutics | Q24596727 | ||
Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
Genetics and biology of pancreatic ductal adenocarcinoma | Q26765438 | ||
Cancer statistics, 2015 | Q27860576 | ||
On the Origin of Cancer Cells | Q27861025 | ||
HMG proteins: dynamic players in gene regulation and differentiation | Q28267498 | ||
Oct4 interaction with Hmgb2 regulates Akt signaling and pluripotency | Q28511152 | ||
SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism | Q28587694 | ||
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen | Q29615061 | ||
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol | Q33691999 | ||
Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected] | Q34043446 | ||
TRIM24 links glucose metabolism with transformation of human mammary epithelial cells | Q35209056 | ||
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer | Q35578938 | ||
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation | Q36907933 | ||
Sugar-free approaches to cancer cell killing | Q37802748 | ||
Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas | Q38034955 | ||
Cancer cell metabolism: one hallmark, many faces. | Q38046274 | ||
Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer. | Q38125169 | ||
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer | Q39491238 | ||
High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness | Q39771568 | ||
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. | Q39814340 | ||
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia | Q40244028 | ||
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. | Q40466820 | ||
Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia | Q41874581 | ||
Metabolic regulation of epigenetics | Q41942880 | ||
Pancreatic Cancer | Q54135367 | ||
High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. | Q54346270 | ||
P433 | issue | 2 | |
P921 | main subject | pancreatic cancer | Q212961 |
P304 | page(s) | 119-127 | |
P577 | publication date | 2017-01-09 | |
P1433 | published in | Acta Biochimica et Biophysica Sinica | Q2183997 |
P1476 | title | Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer | |
P478 | volume | 49 |
Q38711185 | CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer |
Q54966839 | Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression. |
Q49795867 | HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer. |
Q92861973 | HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1α |
Q92404751 | Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1 |
Q64233025 | Knockdown of high mobility group box 3 impairs cell viability and colony formation but increases apoptosis in A549 human non-small cell lung cancer cells |
Q58562101 | Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways |
Q64235593 | Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network |
Q55053728 | Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. |
Search more.